Meticuly Directors Meet Thai Ambassador to the UK to Advance Patient-Specific Implant and Medical Innovation in British Healthcare

His Excellency Mr Nadhavathna Krishnamra, Ambassador of Thailand to the United Kingdom, welcomed executive directors of Meticuly to the Royal Thai Embassy in London.
The meeting brought together Assoc. Prof. Dr Boonrat Lohwongwatana, lecturer at the Faculty of Engineering, Chulalongkorn University, and CEO of Meticuly, alongside Dr Chetarpa Yipyintum, Director of Meticuly Innovations Ltd. based in Cambridge. Discussions focused on strengthening bilateral collaboration in advanced medical device engineering and exploring broader pathways for Thai deep-tech innovations within the UK healthcare ecosystem.
Regulatory Compliance and Entry into the NHS Supply Chain of Patient-Specific Implant
From its origins in university laboratories, Meticuly has developed into a clinical-grade medical technology manufacturer delivering AI-driven, 3D printing Patient-Specific Implants.
The company's translational progress is supported by robust international regulatory benchmarks:
Strengthening the UK Footprint via Meticuly Innovations
During the discussions, Ambassador Nadhavathna Krishnamra, Minister Krisana Cholweerawong, and Minister-Counsellor Charubhumi Ruangsuwan reviewed strategic avenues for scaling high-value health technology partnerships between Thailand and the UK.
Through its regional entity, Meticuly Innovations Ltd. in Cambridge, the company works directly with local clinicians and academic hospitals to refine digital workflows for complex interventions, including Orthognathic Surgery, cranioplasty, and broader reconstructive procedures in Oral and Maxillofacial Surgery. The ability to produce anatomically contoured, patient-matched hardware reduces the necessity for intraoperative plate bending, helping surgical teams streamline operating times and support post-operative recovery.
By combining university-backed materials science with close clinical collaboration, Meticuly continues to convert protected research into validated surgical solutions that deliver measurable benefits to patients across the UK, Thailand, and global healthcare systems.




Comments